Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli

Journal of Infectious Diseases

Volumn 207, Issue 6, 2013, Pages 919-928

  Johnson, James R ^a   Tchesnokova, Veronika ^b   Johnston, Brian ^a   Clabots, Connie ^a   Roberts, Pacita L ^b   Billig, Mariya ^b   Riddell, Kim ^c   Rogers, Peggy ^c   Qin, Xuan ^d   Butler Wu, Susan ^b   Price, Lance B ^e   Aziz, Maliha ^e   Nicolas Chanoine, Marie Hélène ^f   Debroy, Chitrita ^g   Robicsek, Ari ^h   Hansen, Glen ⁱ   Urban, Carl ^j,k   Platell, Joanne ^l   Trott, Darren J ^m   Zhanel, George ⁿ   Weissman, Scott J ^o   Cookson, Brad T ^b   Fang, Ferric C ^b   Limaye, Ajit P ^b   Scholes, Delia ^c   Chattopadhyay, Sujay ^b   Hooper, David C ^p   Sokurenko, Evgeni V ^b   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^f BEAUJON HOSPITAL   (France)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

^h NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

ⁱ HENNEPIN COUNTY MEDICAL CENTER   (United States)

^j NEW YORK HOSPITAL QUEENS   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Animal Disease Surveillance Laboratory   (Australia)

^m UNIVERSITY OF ADELAIDE   (Australia)

ⁿ UNIVERSITY OF MANITOBA   (Canada)

^o SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

antimicrobial resistance; CTX M 15; Escherichia coli infections; extended spectrum lactamase; FimH; fluoroquinolone resistance; molecular epidemiology; multidrug resistance; multilocus sequence typing; sequence type ST131

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL VARIATION; ESCHERICHIA COLI; FIMBRIAL ADHESIN GENE; GENE LOCUS; GYRA GENE; MICROBIAL POPULATION DYNAMICS; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PARC GENE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES;

ADHESINS, ESCHERICHIA COLI; ANTI-BACTERIAL AGENTS; CLONAL EVOLUTION; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE PROTEINS; FLUOROQUINOLONES; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING;

EID: 84874263817     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis933     Document Type: Article

References (26)

1. Gilbert DN, Moellering RCJ, Eliopoulos GM, Chambers HF, Saag MS. The Sanford Guide to Antimicrobial Therapy 2010. 40th ed. Vienna, VA: Antimicrobial Therapy, Inc, 2010:4-64.
2. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect 2003; 5:449-56.
3. Owens RC, Johnson JR, Stogstill P, Yarmus L, Lolans K, Quinn J. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol 2011; 49:3406-8.
4. Tufan Z, Bulut C, Yazan T, et al. A life-threatening Escherichia coli meningitis after prostate biopsy. Urol J 2011; 8:69-71.
5. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-20.
6. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7:337-41.
7. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother 2009; 53:2733-9.
8. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46:2605-12.
9. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin Infect Dis 2010; 51:286-94.
10. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35:316-21.
11. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66:1-14.
12. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
13. Johnson JR, Nicolas-Chanoine M, Debroy C, et al. Comparison of Escherichia coli sequence type ST131 pulsotypes by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012; 18:598-607.
14. Lee MY, Choi HJ, Choi JY, et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infection 2010; 60: 146-53.
15. Cerquetti M, Guifre M, Garcia-Fernandez A, et al. Ciprofloxacinresistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin Microbiol Infect 2010; 16:1555-8.
16. Leflon-Guibout V, Jurand C, Bonacorsi S, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48:3736-42.
17. Platell JL, Cobbold RN, Johnson JR, et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother 2011; 55:3782-7.
18. Weissman SJ, Johnson J, Tchesnokova V, et al. High-resolution twolocus clonal typing of extraintestinal Escherichia coli. Appl Environ Microbiol 2012; 78:1353-60.
19. Swofford DL. PAUP* phylogenetic analysis using parsimony (*and other methods). Version 4. Sunderland, MA: Sinauer Associates, 2003.
20. Clinical and Laboratory Standards Institute. M100-S20: Performance standards for antimicrobial susceptibility testing. 20th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
21. Salvador E, Wagenlehner F, Köhler CD, et al. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012; 80:668-78.
22. Weissman SJ, Chattopadhyay S, Aprikian P, et al. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol 2006; 59:975-88.
23. Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2000; 31(Suppl 2):S24-8.
24. Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc Biol Sci 1997; 264:1287-91.
25. Platell JL, Johnson JR, Cobbold RN, Trott DJ. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 2011; 153:99-108.
26. Russo TA, Johnson JR. Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines 2006; 5:45-54.